Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif

Jin Wen,Hui Liao,Kye Stachowski,Jordan P Hempfling,Ziqing Qian,Chunhua Yuan,Mark P Foster,Dehua Pei,Jordan P. Hempfling,Mark P. Foster
DOI: https://doi.org/10.1016/j.bmc.2020.115711
2020-10-01
Abstract:<p>Cyclic peptides are capable of binding to challenging targets (e.g., proteins involved in protein-protein interactions) with high affinity and specificity, but generally cannot gain access to intracellular targets because of poor membrane permeability. In this work, we discovered a conformationally constrained cyclic cell-penetrating peptide (CPP) containing a D-Pro-L-Pro motif, cyclo(AFΦrpPRRFQ) (where Φ is L-naphthylalanine, r is D-arginine, and p is D-proline). The structural constraints provided by cyclization and the D-Pro-L-Pro motif permitted the rational design of cell-permeable cyclic peptides of large ring sizes (up to 16 amino acids). This strategy was applied to design a potent, cell-permeable, and biologically active cyclic peptidyl inhibitor, cyclo(Y<sup>p</sup>VNFΦrpPRR) (where Y<sup>p</sup> is L-phosphotyrosine), against the Grb2 SH2 domain. Multidimensional NMR spectroscopic and circular dichroism analyses revealed that the cyclic CPP as well as the Grb2 SH2 inhibitor assume a predominantly random coil structure but have significant β-hairpin character surrounding the D-Pro-L-Pro motif. These results demonstrate cyclo(AFΦrpPRRFQ) as an effective CPP for endocyclic (insertion of cargo into the CPP ring) or exocyclic delivery of biological cargos (attachment of cargo to the Gln side chain).</p>
biochemistry & molecular biology,chemistry, medicinal, organic
What problem does this paper attempt to address?
The main problem this paper attempts to address is improving the cell membrane penetration ability of cyclic peptides, thereby enabling them to effectively enter the cell and bind to intracellular protein targets. Specifically, the authors designed a structure-constrained cell-penetrating peptide (CPP) containing a D-Pro-L-Pro motif, which can promote the cyclic peptide to form a β-hairpin structure, thereby enhancing its cell penetration efficiency and target binding affinity. ### Main Problems 1. **Cell Membrane Penetration Issue**: Cyclic peptides typically cannot effectively enter cells due to poor cell membrane penetration, limiting their application on intracellular targets. 2. **Target Binding Affinity and Specificity**: Even if they can enter cells, cyclic peptides need to bind to specific protein targets, such as the Grb2 SH2 domain, with high affinity and specificity. ### Solutions 1. **Design Cyclic Peptides with D-Pro-L-Pro Motif**: By introducing the D-Pro-L-Pro motif, cyclic peptides form a stable β-hairpin structure, thereby improving their cell penetration ability and target binding affinity. 2. **Optimize Amino Acid Composition of Cyclic Peptides**: By adjusting the amino acid composition of cyclic peptides, particularly hydrophobic and charged amino acids, their cell penetration efficiency is further enhanced. 3. **Validate the Biological Activity of Cyclic Peptides**: A cell-penetrating cyclic peptide inhibitor targeting the Grb2 SH2 domain was designed and tested to validate its biological activity and inhibitory effect within cells. ### Experimental Results - **Cell Penetration**: Cyclic peptides containing the D-Pro-L-Pro motif (e.g., peptide 9) exhibited higher cell penetration efficiency, even surpassing known efficient CPPs (e.g., CPP9). - **Target Binding Affinity**: The designed cyclic peptide inhibitors (e.g., peptide 14) showed high binding affinity to the Grb2 SH2 domain and effectively inhibited the Grb2/Ras signaling pathway within cells. - **Structural Characterization**: NMR and circular dichroism analysis confirmed that these cyclic peptides predominantly exist in a random coil structure in solution, but with significant β-hairpin characteristics in surrounding regions. ### Conclusion This study successfully designed an efficient cell-penetrating cyclic peptide that can effectively enter cells and bind to specific protein targets. This discovery provides new strategies and tools for developing novel intracellular targeted drugs.